1don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Add Yahoo as a preferred source to see more of our stories on Google. Killer T cell (orange) attacking cancer (blue). (CREDIT: Alex Ritter) The current path to CAR-T cell therapy is, by any measure, a ...
Each cell in the body has its own unique delivery system that scientists are working on harnessing to move revolutionary biological drugs to specific diseased parts of the body. Researchers found a ...
Scientists from Zhejiang University have developed a novel delivery vehicle for CRISPR-Cas9 that is more effective than lipid nanoparticles (LNPs) in treating lung cancer. Rapid liquid nitrogen ...
Morning Overview on MSN
Researchers find cellular courier system that may aid gene therapies
Getting a therapeutic gene into the right cell has been one of medicine’s most stubborn problems, especially in the brain and ...
SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease -- specifically leukemia -- in a humanized animal model. The results mark a key step in the ...
Researchers headed by a team at Seattle Children’s Research Institute have shown for the first time that engineered human plasma B cells can be used to treat a disease—more specifically leukemia—in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results